State Street’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Buy |
513,026
+43,298
| +9% | +$174K | ﹤0.01% | 3305 |
|
|
2025
Q1 | $1.63M | Buy |
469,728
+12,325
| +3% | +$42.8K | ﹤0.01% | 3315 |
|
|
2024
Q4 | $3.01M | Buy |
457,403
+203,457
| +80% | +$1.34M | ﹤0.01% | 3175 |
|
|
2024
Q3 | $2.3M | Buy |
253,946
+57,674
| +29% | +$521K | ﹤0.01% | 3280 |
|
|
2024
Q2 | $3.15M | Buy |
196,272
+84,057
| +75% | +$1.35M | ﹤0.01% | 3123 |
|
|
2024
Q1 | $1.76M | Buy |
+112,215
| New | +$1.76M | ﹤0.01% | 3321 |
|